Brief: Candel Therapeutics Announces Proposed $100 Million Public Offering
19/02/2026 21:42
Candel Therapeutics Inc CADL.O: CANDEL THERAPEUTICS ANNOUNCES PROPOSED $100 MILLION PUBLIC OFFERING CANDEL THERAPEUTICS INC - PROCEEDS TO FUND AGLATIMAGENE LAUNCH AND PHASE 3 TRIAL COSTS Source text: ID:nGNX4gzjcG Further company coverage: CADL.O
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)